News Discover the latest news stories, blog posts and publications from Cobra's expert team. You are here: Home News Toggle filters Year: All Years 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 or Month: All Months January February March April May June July August September October November December or Type: All Categories DNA Fill Finish General DNA Proteins Technologies Viral Vectors Cobra Biologics Shortlisted for Project of the Year in the Bionow Awards 2016 Viral Vectors Awards Ceremony to be held on Thursday 24th November NEUWAY Pharma and Cobra collaborate to develop GMP grade Engineered Protein Capsules manufacturing process Viral Vectors Collaboration supports GLP toxicity studies and initiation of clinical development for treatment of Progressive Multifocal Leukoencephalopathy Cobra expanderar på CDMO-marknaden för biologiska läkemedel General Artikel i Läkemedelsmarknaden: Cobra expands on the CDMO-market for biological drugs Manufacturer of the Year Finalists in the Staffordshire Business Awards 2016 General Staffordshire Business Awards: Celebrating the best in Staffordshire Cobra Biologics and Alligator Bioscience Extend Drug Development Partnership Project will deliver second cell line for manufacture of immuno-oncology antibody ADC-1015 following ADC-1013 success Cobra and Touchlight Collaborate on Production of Next Generation DNA Constructs DNA Optimising the manufacture of AAV vectors to support gene therapy and regenerative medicine BLOG: A More Balanced Understanding Of “Risk” General Tony Hitchcock's Pharma IQ Blog Cobra and Lancaster partnership helps unravel new analytical tool for DNA topology DNA Lorna Ashton from Lancaster University working with Cobra Biologics to assess a novel method for determining the topology of plasmid DNA. BLOG: The Translation of Next Generation Therapeutics General Tony Hitchcock's Pharma IQ Blog Cobra & CPI to Collaborate on Regenerative Medicine Viral Vectors A project which will focus on the development of an Industrial Manufacturing Platform for Adeno-Associated Virus (AAV) production to support gene therapy and regenerative medicine.... Sheffield University approves Cobra Biologics to advance Growth Hormone antagonist Cobra Biologics Appointed by University of Sheffield to Advance Novel Fusion Protein Technology into Phase 1 Clinical Trials Pagination Go to Previous page Go to page 6 Go to page 7 Go to page 8 Go to page 9 Go to page 10 Go to Next page
Cobra Biologics Shortlisted for Project of the Year in the Bionow Awards 2016 Viral Vectors Awards Ceremony to be held on Thursday 24th November
NEUWAY Pharma and Cobra collaborate to develop GMP grade Engineered Protein Capsules manufacturing process Viral Vectors Collaboration supports GLP toxicity studies and initiation of clinical development for treatment of Progressive Multifocal Leukoencephalopathy
Cobra expanderar på CDMO-marknaden för biologiska läkemedel General Artikel i Läkemedelsmarknaden: Cobra expands on the CDMO-market for biological drugs
Manufacturer of the Year Finalists in the Staffordshire Business Awards 2016 General Staffordshire Business Awards: Celebrating the best in Staffordshire
Cobra Biologics and Alligator Bioscience Extend Drug Development Partnership Project will deliver second cell line for manufacture of immuno-oncology antibody ADC-1015 following ADC-1013 success
Cobra and Touchlight Collaborate on Production of Next Generation DNA Constructs DNA Optimising the manufacture of AAV vectors to support gene therapy and regenerative medicine
Cobra and Lancaster partnership helps unravel new analytical tool for DNA topology DNA Lorna Ashton from Lancaster University working with Cobra Biologics to assess a novel method for determining the topology of plasmid DNA.
Cobra & CPI to Collaborate on Regenerative Medicine Viral Vectors A project which will focus on the development of an Industrial Manufacturing Platform for Adeno-Associated Virus (AAV) production to support gene therapy and regenerative medicine....
Sheffield University approves Cobra Biologics to advance Growth Hormone antagonist Cobra Biologics Appointed by University of Sheffield to Advance Novel Fusion Protein Technology into Phase 1 Clinical Trials